Inactivation of PI3K/AKT Signaling Inhibits Glioma Cell Growth Through Modulation of Β-Catenin-mediated Transcription

LAN Feng-ming,YUE Xiao,HAN Lei,SHI Zhen-dong,YANG Yang,ZOU Jian,ZHANG An-ling,WANG Guang-xiu,JIA Zhi-fan,PU Pei-yu,KANG Chun-sheng
DOI: https://doi.org/10.3760/cma.j.issn.1001-2346.2012.03.019
2012-01-01
Abstract:Objective To investigate the mechanism of PI3K/AKT signaling inhibitor LY294002 decreasing cell proliferation and invasive ability.Motheds The phosphatidylinositol 3' - kinase (PI3K)inhibitor LY294002(Sigma) and DMSO were added into LN229 cells,respectively.Western blot was used to detect the expression of p - AKT to show the effect of LY294002.The biological behavior changes of LN229 cells were evaluated by MTT,FCM and Transwell assay.Western blot was also undertaken to analyze the expression of some functional proteins related to β - catenin/Wnt signaling.Results PI3K/AKT inhibitor LY294002 dramatically down regulated the expression of p - AKT in LN229 cells.Inhibition of PI3K/AKT signaling with LY294002 suppressed proliferation of LN229 cells determined by MTT assay compared with DMSO and control groups.LY294002 significantly decreased the S phase fraction to 5.5% from 17.8% and 17.3% in the parental and DMSO treated groups,respectively.Transwell assay demonstrated decreased invasion capability of LN229 cell lines based on LY294002.Initial studies revealed that increasing concentration of LY294002 resulted in decreased expression of β - catenin,p - GSK - 3β,c - Myc and Cyclin D1.Conclusion These results suggest that the PI3K/AKT signaling pathway regulates glioma cell proliferation,in part via repression of the Wnt/β- catenin pathway.
What problem does this paper attempt to address?